An Analysis of the Changes in the Sarcoma Tumor Immune Microenvironment Following Trabectedin
Phase of Trial: Phase II
Latest Information Update: 29 Dec 2018
At a glance
- Drugs Trabectedin (Primary)
- Indications Sarcoma
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 31 Jul 2018 Status changed from not yet recruiting to recruiting.
- 08 Feb 2018 Planned End Date changed from 1 Feb 2019 to 1 May 2019.